A study led by Roswell Park Comprehensive Cancer Center provides new insight into the complex interactions of the ...

Marcus Evans is proud to announce the Evolution Summit 2025, an exclusive, invitation-only event that will unite leading clinical trial executives with innovative suppliers and solution providers in ...

Natera has begun the subject enrolment in the randomised Phase III SAGITTARIUS clinical trial designed to assess the ...

The Phase I expansion trial saw a 25.9% overall response rate (ORR) for endometrial cancer and 37.5% in platinum-resistant ...

Natera (NTRA) announced the enrollment of the first patients in the SAGITTARIUS clinical trial. Sponsored by The AIRC ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Two days after the FDA revealed that it had halted enrollment in trials of respiratory syncytial virus (RSV) vaccines that ...

Boundless Bio’s freshman year on the public markets hasn’t been easy, with “modest” layoffs in the summer followed by news ...

An experimental hormone therapy pill has shown promise in extending the lives of women with tough-to-treat advanced br ...

A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer.According ...

In 2018 an investigation by the International Consortium of Investigative Journalists revealed that 83,000 deaths and over ...

Hopes of a bright new future in stroke risk management in AF were dashed when asundexian failed against apixaban in the ...